Company outlines clinical plan for LYR-210 based on FDA meeting on the path to NDA submission Positive ENLIGHTEN 2 results highlighted at the ...

If you have anything you want to share with us, send us an e-mail at [email protected]!

Preclinical data presented at the European Society of Gene and Cell Therapy (ESGCT) highlight a potential best-in-class profile--The AATD ...

Aquestive Therapeutics leverages its PharmFilm platform to develop Anaphylm, a sublingual epinephrine film, a $1B+ market.

Sagimet is a clinical-stge biopharmaceutical company developing novel fatty acid synthase (FASN) inhibitors that are designed to target dysfunctional metabolic and fibrotic pathways in diseases ...

The Company continues to expand its current ADC pipeline to encompass multiple targets, such as AKTX-101 (Trop2 ADC with PH1 payload), as well as future programs (AKTX-102, undisclosed target with PH1 ...

Art Basel Qatar will feature 84 artist presentations by 87 galleries when the fair debuts in Doha next February. Presented in ...

Strong interest has resulted in the the fair having upwards of 50% more participants than anticipated, organisers say ...

A CRISPR-Cas9-based therapy targeting the gene encoding transthyretin greatly reduced transthyretin levels in patients with ...

Shattuck Labs, Inc. ( NASDAQ: STTK) The United European Gastroenterology (UEG) Congress UEG Week 2025 October 8, 2025 10:00 AM EDT ...

Adults with Duchenne muscular dystrophy demonstrated functional improvements exceeding natural history, following 28-day treatment with SAT-3247Grip strength increased 118.6% and predicted forced ...

Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company") today announced that it will report its Third Quarter 2025 Earnings Results on Wednesday, October 22, 2025, after ...